share_log

Wells Fargo Maintains Overweight on United Therapeutics, Raises Price Target to $380

Benzinga ·  Aug 21 00:21  · Ratings

Wells Fargo analyst Tiago Fauth maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $350 to $380.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment